NPCE
Neuropace Inc
14.10$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -2.25 | -1.95 | -1.48 | -1.50 | -0.76 | -0.62 | -0.34 | |
| 0.04 | 0.03 | 0.02 | 0.12 | 0.06 | 0.06 | 0.06 | |
| 0.13 | 0.12 | 0.26 | 0.34 | 0.37 | 0.35 | 0.34 | |
| 0.19 | 0.08 | 0.59 | 0.44 | – | – | – | |
| 0.00 | -0.19 | 0.02 | -0.19 | -0.10 | -0.19 | -0.12 | |
| 0.04 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| 0.33 | -0.97 | -5.14 | 0.97 | 0.89 | 0.31 | -0.01 | |
| – | – | 6.42 | 0.00 | -0.01 | 0.00 | -1.51 | |
| 1.92 | 2.20 | -0.25 | 0.00 | – | 0.00 | -0.06 | |
| 1.92 | 4.95 | 6.17 | 0.02 | 0.31 | 0.15 | 0.60 | |
| 0.00 | 2.04 | -0.45 | -0.51 | 0.44 | -0.16 | 0.25 | |
| -2.30 | -1.95 | -1.50 | -1.52 | -0.77 | -0.63 | -0.35 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.